Hemobiotech, INC.
SEC CIK 1301348 · HMBT.OB · last insider filing 2010-12-17
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Nino Ghassan | Director | filed 2006 - 2010 |
| Bollon Arthur | Director · Chief Executive Officer | filed 2008 - 2010 |
| Comer Robert | Director · InterimChief Financial Officer | filed 2006 - 2010 |
| Mittemeyer Bernhard | Director | filed 2006 - 2010 |
| Baron Robert | Director | filed 2006 - 2010 |
| Dragoo Robert E. | Director | filed 2009 - 2010 |
| Haeussler Walter | Director | filed 2006 - 2008 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Rosenblum Mark J | Chief Financial Officer | filed 2006 - 2009 |
| Simoni Jan | Acting VP | filed 2006 - 2006 |
| Feola Mario | Officer | filed 2006 - 2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.